Spyros Papapetropoulos - 08 Jun 2022 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Director
Signature
/s/ Spyros Papapetropoulos
Issuer symbol
LPCN
Transactions as of
08 Jun 2022
Net transactions value
+$20,240
Form type
4
Filing time
10 Jun 2022, 11:34:11 UTC
Previous filing
04 May 2022
Next filing
22 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $20,240 +22,000 +220% $0.9200 32,000 08 Jun 2022 Common Stock 22,000 $0.9200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby all of the shares subject to the award will vest on the one year anniversary of June 8, 2023.